{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:17:39Z","timestamp":1792783059800,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hebrew University of Jerusalem","id":[{"id":"https:\/\/ror.org\/03qxff017","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-026-02248-3","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:50:02Z","timestamp":1771498202000},"page":"1859-1869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immediate vs delayed left bundle branch block after transcatheter aortic valve replacement: incidence and risk factors for permanent pacemaker implantation"],"prefix":"10.1007","volume":"69","author":[{"given":"Maayan","family":"Shrem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oholi","family":"Tovia-Brodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Rav Acha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziv","family":"Dadon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Zabern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimrod","family":"Perel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Dvir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Glikson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Michowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"2248_CR1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1161\/CIRCULATIONAHA.117.028352","volume":"136","author":"V Auffret","year":"2017","unstructured":"Auffret V, Puri R, Urena M, Chamandi C, Rodriguez-Gabella T, Philippon F, et al. Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives. Circulation. 2017;136:1049\u201369.","journal-title":"Circulation"},{"key":"2248_CR2","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jacc.2019.07.014","volume":"74","author":"J Rodes-Cabau","year":"2019","unstructured":"Rodes-Cabau J, Ellenbogen KA, Krahn AD, Latib A, Mack M, Mittal S, et al. Management of conduction disturbances associated with transcatheter aortic valve replacement: JACC scientific expert panel. J Am Coll Cardiol. 2019;74:1086\u2013106.","journal-title":"J Am Coll Cardiol"},{"key":"2248_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/europace\/euab232","volume":"24","author":"M Glikson","year":"2022","unstructured":"Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022;24:71\u2013164.","journal-title":"Europace"},{"key":"2248_CR4","doi-asserted-by":"crossref","unstructured":"Perel N, Tovia-Brodie O, Schnur A, Acha MR, Levi N, Cohen Y, Dvir D, Glikson M, Michowitz Y. Post-transcatheter aortic valve implantation isolated PR prolongation: incidence and clinical significance. Europace. 2023;26.","DOI":"10.1093\/europace\/euae011"},{"key":"2248_CR5","doi-asserted-by":"crossref","unstructured":"Michowitz Y, Yagel O, Shrem M, et al. New-Onset RBBB after transcatheter aortic valve replacement: incidence and risk factors for permanent pacemaker implantation. JACC Clin Electrophysiol. 2025.","DOI":"10.1016\/j.jacep.2025.06.013"},{"key":"2248_CR6","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.jacc.2012.07.035","volume":"60","author":"M Urena","year":"2012","unstructured":"Urena M, Mok M, Serra V, et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol. 2012;60:1743\u201352.","journal-title":"J Am Coll Cardiol"},{"key":"2248_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jcin.2013.08.015","volume":"7","author":"M Urena","year":"2014","unstructured":"Urena M, Webb JG, Cheema A, et al. Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2014;7:128\u201336.","journal-title":"JACC Cardiovasc Interv"},{"key":"2248_CR8","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/eurheartj\/ehr110","volume":"32","author":"RJ Nuis","year":"2011","unstructured":"Nuis RJ, Van Mieghem NM, Schultz CJ, Tzikas A, Van der Boon RM, Maugenest AM, et al. Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur Heart J. 2011;32:2067\u201374.","journal-title":"Eur Heart J"},{"key":"2248_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.hrthm.2020.10.018","volume":"18","author":"C Reiter","year":"2021","unstructured":"Reiter C, Lambert T, Kellermair J, Blessberger H, Fellner A, Strasser B, et al. Intraprocedural dynamics of cardiac conduction during transcatheter aortic valve implantation: Assessment by simultaneous electrophysiological testing. Heart Rhythm. 2021;18:419\u201325.","journal-title":"Heart Rhythm"},{"key":"2248_CR10","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.4244\/EIJV9I10A194","volume":"9","author":"P Houthuizen","year":"2014","unstructured":"Houthuizen P, van der Boon RM, Urena M, Van Mieghem N, Brueren GB, Poels TT, et al. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention. 2014;9:1142\u201350.","journal-title":"EuroIntervention"},{"key":"2248_CR11","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1093\/europace\/euy074","volume":"20","author":"L van Gils","year":"2018","unstructured":"van Gils L, Baart S, Kroon H, et al. Conduction dynamics after transcatheter aortic valve implantation and implications for permanent pacemaker implantation and early discharge: the CONDUCT-study. Europace. 2018;20:1981\u20138.","journal-title":"Europace"},{"key":"2248_CR12","doi-asserted-by":"publisher","first-page":"100428","DOI":"10.1016\/j.shj.2025.100428","volume":"9","author":"AP Chua","year":"2025","unstructured":"Chua AP, Myagmardorj R, Nabeta T, Kuneman JH, van der Kley F, Bax JJ, et al. Conduction disorders after transcatheter aortic valve implantation evolution over time and association with long-term outcomes. Struct Heart. 2025;9:100428.","journal-title":"Struct Heart"},{"key":"2248_CR13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.jacc.2008.12.013","volume":"53","author":"B Surawicz","year":"2009","unstructured":"Surawicz B, Childers R, Deal BJ, et al. AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009;53:976\u201381.","journal-title":"J Am Coll Cardiol"},{"key":"2248_CR14","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1093\/eurheartj\/ehz924","volume":"41","author":"L Faroux","year":"2020","unstructured":"Faroux L, Chen S, Muntane-Carol G, Regueiro A, Philippon F, Sondergaard L, et al. Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis. Eur Heart J. 2020;41:2771\u201381.","journal-title":"Eur Heart J"},{"key":"2248_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10840-016-0218-2","volume":"48","author":"O Tovia-Brodie","year":"2017","unstructured":"Tovia-Brodie O, Ben-Haim Y, Joffe E, Finkelstein A, Glick A, Rosso R, et al. The value of electrophysiologic study in decision-making regarding the need for pacemaker implantation after TAVI. J Interv Card Electrophysiol. 2017;48:121\u201330.","journal-title":"J Interv Card Electrophysiol"},{"key":"2248_CR16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.hrthm.2023.01.013","volume":"20","author":"G Massoullie","year":"2023","unstructured":"Massoullie G, Ploux S, Souteyrand G, et al. Incidence and management of atrioventricular conduction disorders in new-onset left bundle branch block after TAVI: A prospective multicenter study. Heart Rhythm. 2023;20:699\u2013706.","journal-title":"Heart Rhythm"},{"key":"2248_CR17","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1161\/CIRCULATIONAHA.112.001099","volume":"127","author":"L Testa","year":"2013","unstructured":"Testa L, Latib A, De Marco F, et al. Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve Revalving System. Circulation. 2013;127:1300\u20137.","journal-title":"Circulation"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02248-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02248-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02248-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:54:36Z","timestamp":1792572876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02248-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":17,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2248"],"URL":"https:\/\/doi.org\/10.1007\/s10840-026-02248-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8121179\/v1","asserted-by":"object"}]},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"YM: Consultant for Edwards Lifesciences (Irvine, California); DD: Consultant and proctor for Medtronic cardiovascular (Minneapolis, Minnesota) and Edwards Lifesciences (Irvine, California); MG advisory board Medtronic cardiovascular (Minneapolis, Minnesota). All other authors declare having no potential conflict of interest.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"YM: Consultant for Edwards Lifesciences (Irvine, California); DD: Consultant and proctor for Medtronic cardiovascular (Minneapolis, Minnesota) and Edwards Lifesciences (Irvine, California); MG advisory board Medtronic cardiovascular (Minneapolis, Minnesota). All other authors declare having no potential conflict of interest.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}